Strategies to Account for Design Misspecifications in Randomized Controlled Trials.

NEJM Evid

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.

Published: April 2022

Mortality rates of infants (younger than 1 year of age) and neonates (younger than 1 month of age) remain unacceptably high in some geographic regions. After the first week of life, infection is a significant cause of neonatal and postneonatal mortality. Biannual mass azithromycin administration has been shown to reduce all-cause childhood mortality by as much as 25% among infants 1 to 5 months of age in Niger..

Download full-text PDF

Source
http://dx.doi.org/10.1056/EVIDe2200012DOI Listing

Publication Analysis

Top Keywords

strategies account
4
account design
4
design misspecifications
4
misspecifications randomized
4
randomized controlled
4
controlled trials
4
trials mortality
4
mortality rates
4
rates infants
4
infants younger
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!